BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7629226)

  • 1. Familial bilateral macronodular adrenal hyperplasia due to a novel ARMC 5 germline mutation: Clinical status and possible association with other neoplasms.
    Piñar-Gutiérrez A; Mangas-Cruz MÁ; de Lara-Rodríguez I; Remón-Ruiz P; Del Can-Sánchez D; Tous Castillo M; Pumar-López A
    Endocrinol Diabetes Nutr (Engl Ed); 2024 Mar; 71(3):119-123. PubMed ID: 38555108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and cardiac characteristics of primary bilateral macronodular adrenal hyperplasia.
    Miao S; Lu L; Si S; Peng D; Zhong Y; Li Z; Yu Z
    J Med Biochem; 2024 Jan; 43(1):19-35. PubMed ID: 38496019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of adrenal P450 aromatase (CYP19A1) in association with ARMC5-primary bilateral macronodular adrenocortical hyperplasia.
    Berthon A; Hannah-Shmouni F; Maria AG; Faucz FR; Stratakis CA
    J Steroid Biochem Mol Biol; 2019 Jul; 191():105316. PubMed ID: 31014964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful Treatment of Estrogen Excess in Primary Bilateral Macronodular Adrenocortical Hyperplasia with Leuprolide Acetate.
    Hannah-Shmouni F; Moraitis AG; Romero VV; Faucz FR; Mastroyannis SA; Berthon A; Failor RA; Merino M; Demidowich AP; Stratakis CA
    Horm Metab Res; 2018 Feb; 50(2):124-132. PubMed ID: 29183089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arginine vasopressin (AVP): a review of its historical perspectives, current research and multifunctional role in the hypothalamo-hypophysial system.
    Rotondo F; Butz H; Syro LV; Yousef GM; Di Ieva A; Restrepo LM; Quintanar-Stephano A; Berczi I; Kovacs K
    Pituitary; 2016 Aug; 19(4):345-55. PubMed ID: 26762848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ARMC5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional Consequences.
    Espiard S; Drougat L; Libé R; Assié G; Perlemoine K; Guignat L; Barrande G; Brucker-Davis F; Doullay F; Lopez S; Sonnet E; Torremocha F; Pinsard D; Chabbert-Buffet N; Raffin-Sanson ML; Groussin L; Borson-Chazot F; Coste J; Bertagna X; Stratakis CA; Beuschlein F; Ragazzon B; Bertherat J
    J Clin Endocrinol Metab; 2015 Jun; 100(6):E926-35. PubMed ID: 25853793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the nonpressor and nonantidiuretic actions of the hormone vasopressin.
    Mavani GP; DeVita MV; Michelis MF
    Front Med (Lausanne); 2015; 2():19. PubMed ID: 25853137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and clinical evidence for an ARMC5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningioma.
    Elbelt U; Trovato A; Kloth M; Gentz E; Finke R; Spranger J; Galas D; Weber S; Wolf C; König K; Arlt W; Büttner R; May P; Allolio B; Schneider JG
    J Clin Endocrinol Metab; 2015 Jan; 100(1):E119-28. PubMed ID: 25279498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACTH-independent macronodular adrenocortical hyperplasia reveals prevalent aberrant in vivo and in vitro responses to hormonal stimuli and coupling of arginine-vasopressin type 1a receptor to 11β-hydroxylase.
    Hofland J; Hofland LJ; van Koetsveld PM; Steenbergen J; de Herder WW; van Eijck CH; de Krijger RR; van Nederveen FH; van Aken MO; de Groot JW; Links TP; de Jong FH; Feelders RA
    Orphanet J Rare Dis; 2013 Sep; 8():142. PubMed ID: 24034279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors.
    Hsiao HP; Kirschner LS; Bourdeau I; Keil MF; Boikos SA; Verma S; Robinson-White AJ; Nesterova M; Lacroix A; Stratakis CA
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2930-7. PubMed ID: 19509103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of hormone receptors in adrenal Cushing's syndrome.
    Christopoulos S; Bourdeau I; Lacroix A
    Pituitary; 2004; 7(4):225-35. PubMed ID: 16010457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inherited adrenocorticotropin-independent macronodular adrenal hyperplasia with abnormal cortisol secretion by vasopressin and catecholamines: detection of the aberrant hormone receptors on adrenal gland.
    Miyamura N; Taguchi T; Murata Y; Taketa K; Iwashita S; Matsumoto K; Nishikawa T; Toyonaga T; Sakakida M; Araki E
    Endocrine; 2002 Dec; 19(3):319-26. PubMed ID: 12624433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of severe hypertension caused by ACTH-independent macronodular adrenal hyperplasia.
    Nocente R; De ML; Mancini A; Bianchi A; Bellantone R; Lauriola L; Costanzo M; De CC; Gasbarrini G; Gentiloni SN
    J Endocrinol Invest; 2002 Mar; 25(3):254-8. PubMed ID: 11936469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case of adrenocorticotropic hormone-independent macronodular adrenal hyperplasia with possible adrenal hypersensitivity to angiotensin II.
    Nakamura Y; Son Y; Kohno Y; Shimono D; Kuwamura N; Koshiyama H; Sasano H; Matsuda T
    Endocrine; 2001 Jun; 15(1):57-61. PubMed ID: 11572327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysine vasopressin stimulation of cortisol secretion in patients with adrenocorticotropin-independent macronodular adrenal hyperplasia.
    Horiba N; Suda T; Aiba M; Naruse M; Nomura K; Imamura M; Demura H
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2336-41. PubMed ID: 7629226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenocorticotrophin-independent macronodular adrenal hyperplasia in a patient with lysine vasopressin responsiveness but insensitivity to gastric inhibitory polypeptide.
    Iida K; Kaji H; Matsumoto H; Okimura Y; Abe H; Fujisawa M; Kamidono S; Chihara K
    Clin Endocrinol (Oxf); 1997 Dec; 47(6):739-45. PubMed ID: 9497882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial adrenocorticotropin-independent Cushing's syndrome with bilateral macronodular adrenal hyperplasia.
    Findlay JC; Sheeler LR; Engeland WC; Aron DC
    J Clin Endocrinol Metab; 1993 Jan; 76(1):189-91. PubMed ID: 8380604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cushing's syndrome: diagnostic exploration].
    Tabarin A; Roger P
    Presse Med; 1994 Jan 8-15; 23(1):43-8. PubMed ID: 8127815
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.